Boltz-2 Changes the Economics of Structure-Based Drug Design

MIT's open-weight model matches AlphaFold3 on protein-ligand complexes while running on a single GPU. For computational chemistry teams, the implications for hit-to-lead timelines are significant — and immediate.

By BT Research